Self-Evaluation of Negative Symptoms: A Novel Tool to Assess Negative Symptoms.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Schizophrenia bulletin

• Publication date

  2016-05-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1093/schbul/sbv161PMID 26564898PMCID PMC4838089
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dimensional symptom severity and global cognitive function predict subjective quality of life in patients with schizophrenia and healthy adults.

  2017cited by this paper
• [Scale for assessing negative symptoms in schizophrenia: A systematic review].

  2016cited by this paper
• Reliability and validity of a Brief Self‐rated Scale of Health Condition with Acute Schizophrenia

  2014cited by this paper
• Persistent negative symptoms in first episode patients with schizophrenia: results from the European First Episode Schizophrenia Trial.

  2013cited by this paper
• Negative symptom measurement in individuals at-risk for psychosis.

  2013cited by this paper
• The Clinical Assessment Interview for Negative Symptoms (CAINS): final development and validation.

  2013cited by this paper
• Self-reported quality of life measure is reliable and valid in adult patients suffering from schizophrenia with executive impairment.

  2013cited by this paper
• The Motivation and Pleasure Scale-Self-Report (MAP-SR): reliability and validity of a self-report measure of negative symptoms.

  2013cited by this paper
• Screening for negative symptoms: preliminary results from the self-report version of the Clinical Assessment Interview for Negative Symptoms.

  2012cited by this paper
• Negative symptoms in individuals at clinical high risk of psychosis.

  2012cited by this paper
• Next-generation negative symptom assessment for clinical trials: validation of the Brief Negative Symptom Scale.

  2012cited by this paper
• The brief negative symptom scale: psychometric properties.

  2011cited by this paper
• Persistent negative symptoms in first-episode schizophrenia: a prospective three-year follow-up study.

  2011cited by this paper
• Are screening instruments valid for psychotic-like experiences? A validation study of screening questions for psychotic-like experiences using in-depth clinical interview.

  2011cited by this paper
• Assessment of negative symptoms and depression in schizophrenia: revision of the SANS and how it relates to the PANSS and CDSS.

  2011cited by this paper
• Standardised rating scales in Psychiatry: Methodological basis, their possibilities and limitations and descriptions of important rating scales

  2009cited by this paper
• How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials

  2009cited by this paper
• A self-reported instrument for prodromal symptoms of psychosis: testing the clinical validity of the PRIME Screen-Revised (PS-R) in a Japanese population.

  2008cited by this paper
• A meta-analysis of controlled research on social skills training for schizophrenia.

  2008cited by this paper
• Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure.

  2007cited by this paper
• The association of insight with psychotic symptoms, depression, and cognition in early psychosis: a 3-year follow-up.

  2007cited by this paper
• Quality of life and functioning ability in subjects vulnerable to psychosis.

  2007cited by this paper
• The validity of using patient self-report to assess psychotic symptoms in schizophrenia.

  2007cited by this paper
• Are self-reports valid for schizophrenia patients with poor insight? Relationship of unawareness of illness to psychological self-report instruments.

  2007cited by this paper
• The structure of negative symptoms within schizophrenia: implications for assessment.

  2006cited by this paper
• The NIMH-MATRICS consensus statement on negative symptoms.

  2006cited by this paper
• Impairments of executive/attentional functions in schizophrenia with primary and secondary negative symptoms.

  2005cited by this paper
• Manual for the Extrapyramidal Symptom Rating Scale (ESRS)

  2005cited by this paper
• Examining the latent structure of negative symptoms: is there a distinct subtype of negative symptom schizophrenia?

  2005cited by this paper
• The subjective quality of life in deficit and nondeficit schizophrenic patients

  2005cited by this paper
• Perceived functioning, well-being and psychiatric symptoms in patients with stable schizophrenia treated with long-acting risperidone for 1 year.

  2005cited by this paper
• Manual for the Extrapyramidal Symptom Rating Scale (ESRS).

  2005cited by this paper
• Using Self-Rating Scales for Assessing the Severely Mentally Ill Client

  2005cited by this paper
• The relationship between insight and symptoms in schizophrenia.

  2004cited by this paper
• Agreement Between Self-Rated and Clinically Assessed Symptoms in Subjects With Psychosis

  2004cited by this paper
• [Negative symptoms of schizophrenic patients from the perspective of psychiatrists, patients themselves and their relatives].

  2003cited by this paper
• Negative Symptome schizophrener Patienten aus der Perspektive der Psychiater, der Patienten selbst und deren Angehörigen

  2003cited by this paper
• Patient-rated versus clinician-rated side effects of drug treatment in schizophrenia. Clinical validation of a self-rating version of the UKU Side Effect Rating Scale (UKU-SERS-Pat)

  2001cited by this paper
• Study of the concurrent validity of the Calgary Depression Scale for Schizophrenics (CDSS).

  2000cited by this paper
• Clinical predictors of discrepancy between self-ratings and examiner ratings for negative symptoms.

  2000cited by this paper
• Objective and Subjective Extrapyramidal Side Effects in Schizophrenia: Their Relationships with Negative and Depressive Symptoms

  2000cited by this paper
• Long‐term course of schizophrenic, affective and schizoaffective psychosis: focus on negative symptoms and their impact on global indicators of outcome

  2000cited by this paper
• Deficit syndromes in schizophrenic patients 15 years after their first hospitalisation: preliminary results of a follow-up study

  1999cited by this paper
• A psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale.

  1996cited by this paper
• Validity of self-administered symptom scales in clients with schizophrenia and schizoaffective disorders.

  1996cited by this paper
• Focus Groups in Mental Health Research: Enhancing the Validity of User and Provider Questionnaires

  1996cited by this paper
• How to distinguish between the neuroleptic-induced deficit syndrome, depression and disease-related negative symptoms in schizophrenia

  1995cited by this paper
• Negative symptoms in schizophrenia: their evolution during an acute phase.

  1995cited by this paper
• [Comparison of 2 depression scales and their relationship with negative and akinetic symptoms in stabilized schizophrenic patients].

  1994cited by this paper
• A self‐report Insight Scale for psychosis: reliability, validity and sensitivity to change

  1994cited by this paper
• A multisite investigation of the reliability of the Scale for the Assessment of Negative Symptoms.

  1994cited by this paper
• [Schedule for evaluation of the deficit syndrome in schizophrenia: Schedule for Deficit Syndrome (SDS) (Kirkpatrick et al.). Importance pertinence of the SDS. Introduction of the French version].

  1994cited by this paper
• The subjective experience of negative symptoms: a self-rating scale.

  1993cited by this paper
• Assessing Depression in Schizophrenia: The Calgary Depression Scale

  1993cited by this paper
• Negative Symptoms in Schizophrenia

  1990cited by this paper
• The measurement of subjective experience in schizophrenia: the Subjective Deficit Syndrome Scale.

  1990cited by this paper
• The Schedule for the Deficit syndrome: an instrument for research in schizophrenia.

  1989cited by this paper
• The subjective experience of deficits in schizophrenia.

  1988cited by this paper
• The positive and negative syndrome scale (PANSS) for schizophrenia.

  1987cited by this paper
• The Brief Psychiatric Rating Scale

  1962cited by this paper

• Predicting negative symptoms: a novel scale for assessing anticipatory cognitive mechanisms in psychosis

  2026cites this paper
• Study protocol for a randomized clinical pilot trial investigating feasibility and efficacy of augmenting a virtual reality-assisted intervention targeting auditory verbal hallucinations with biofeedback: The Neuro-VR study.

  2026cites this paper
• Subjective and objective assessment of negative symptoms in patients with schizophrenia and their clinical and functional associations

  2026cites this paper
• Working memory and learning impairments in deficit and non-deficit schizophrenia, and their associations with negative symptoms: A mediation analysis

  2025cites this paper
• Gesture deficits in psychosis and the combination of group psychotherapy and transcranial magnetic stimulation: A randomized clinical trial

  2025cites this paper
• Gesture Impairments in Schizophrenia: Distinct Roles of Negative Symptoms and Formal Thought Disorder.

  2025cites this paper
• Alleviating negative symptoms in schizophrenia using a virtual reality-based therapy targeting social reward learning (ENGAGE): Protocol for a randomised, controlled, assessor-blind pilot study

  2025cites this paper
• Impaired effort allocation in schizophrenia

  2025cites this paper
• The Relationship Between Insomnia and Depressive Symptoms in a Sample of Patients With Schizophrenia: Do Psychotic Symptoms Play a Mediating Role?

  2025cites this paper
• Analysis of language patterns in schizophrenia based on natural language processing.

  2025cites this paper
• Naturalistic Psychedelic Use and Psychotic Symptoms: A Cross-Sectional Study of Individuals with a Personal or Family History of Psychotic or Bipolar Disorders

  2025influential citation
• Negative symptoms in psychosis: A scoping review of qualitative studies.

  2025cites this paper
• French Validation of the Brief Negative Symptom Scale (BNSS)

  2025cites this paper
• Pharmacological Interventions for Negative Symptoms in Schizophrenia: A Systematic Review of Randomised Control Trials

  2025cites this paper
• Systematic Review of Self-Assessment Scales for Negative Symptoms in Schizophrenia

  2025influential citation
• A Mobile Health Intervention to Support Collaborative Decision-Making in Mental Health Care: Development and Usability

  2025cites this paper
• Avolition Characterizes the Chronic Fatigue Experienced in Quiescent Inflammatory Bowel Disease

  2025cites this paper
• Insight differences between deficit and non-deficit schizophrenia: a systematic review and meta-analysis.

  2025cites this paper
• Increasing physical activity and reducing sedentary behaviour in patients diagnosed with non-affective psychosis: a cross-sectional UK study identifying cognitions to target in treatment

  2025cites this paper
• Prevalence of Primary, Prominent, and Predominant Negative Symptoms of Schizophrenia in Routine Inpatient Psychiatric Care

  2025cites this paper
• Can We Detect the Undetected? Comparing the Prodromes of Individuals with First Episode Psychosis Detected and Undetected by Clinical High-Risk for Psychosis Services: An Electronic Health Record Study.

  2025cites this paper
• Self-assessment scale of auditory verbal hallucinations (SAVH): A novel tool for patients with schizophrenia.

  2024cites this paper
• Dutch Validation of the Self-Evaluation of Negative Symptoms Scale (SNS)

  2024influential citation
• Innovations thérapeutiques dans la prise en charge de la schizophrénie

  2024cites this paper
• The moderating role of COMT gene rs4680 polymorphism between maladaptive metacognitive beliefs and negative symptoms in patients with schizophrenia

  2024cites this paper
• Non-optimal cognitive offloading in schizophrenia in a prospective memory task: Influence of both metacognitive beliefs and cognitive effort avoidance.

  2024cites this paper
• Peripersonal Space Plasticity in Relation to Psychopathology and Anomalous Subjective Experiences in Individuals With Early‐Onset and Adult‐Onset Schizophrenia

  2024cites this paper
• The relationship between mindfulness and empathy with the oxytocinergic system in persons with schizophrenia spectrum disorders – A proof-of-concept randomized controlled trial (OXYGEN)

  2024influential citation
• The Impact of Childhood Trauma on the Negative Symptoms of Schizophrenia

  2024cites this paper
• The Relationship Between Psychosis and Psychological Flexibility and Other Acceptance and Commitment Therapy Processes: A Systematic Review and Meta-Analysis

  2024cites this paper
• Impulsivity and inhibitory control in deficit and non-deficit schizophrenia

  2024cites this paper
• The management of patients with predominant negative symptoms in Slovakia: A 1-year longitudinal, prospective, multicentric cohort study

  2024influential citation
• Striatal Functional Hypoconnectivity in Patients With Schizophrenia Suffering From Negative Symptoms, Longitudinal Findings.

  2024cites this paper
• Psychometric properties of the Spanish version of the Chalder Fatigue Scale in clinical and general populations

  2024cites this paper
• Adaptive coding of reward in schizophrenia, its change over time and relationship to apathy

  2024cites this paper
• Revealing the Unseen: Detecting Negative Symptoms in Students

  2024influential citation
• The Swedish version of the Motivation and Pleasure Scale self-report (MAP-SR): psychometric properties in patients with schizophrenia or depression

  2024cites this paper
• Motiv8: a study protocol for a cluster-randomised feasibility trial of a weight management intervention for adults with severe mental illness in secure forensic services

  2024cites this paper
• Psychomotor Slowing in Psychosis and Inhibitory Repetitive Transcranial Magnetic Stimulation

  2024cites this paper
• Effectiveness of a mindfulness-based intervention for persons with early psychosis: A multi-site randomized controlled trial.

  2024cites this paper
• Language and communication rehabilitation in patients with schizophrenia: A narrative review

  2024cites this paper
• The combination of oxytocin and mindfulness-based group therapy for empathy and negative symptoms in schizophrenia spectrum disorders - A double-blinded, randomized, placebo-controlled pilot study.

  2024cites this paper
• The Self-Evaluation of Negative Symptoms in Differentiating Deficit Schizophrenia: The Comparison of Sensitivity and Specificity with Other Tools

  2023cites this paper
• Study protocol for a randomized controlled trial with rituximab for psychotic disorder in adults (RCT-Rits)

  2023cites this paper
• Virtual reality supported therapy for the negative symptoms of schizophrenia: the V-NeST feasibility RCT

  2023cites this paper
• Evaluation of a new intrinsic and extrinsic motivation scale in youth with psychosis spectrum symptoms

  2023cites this paper
• Exploring negative symptoms heterogeneity in patients diagnosed with schizophrenia and schizoaffective disorder using cluster analysis

  2023influential citation
• Correlation Between Efficacy of Treatment with Anti-psychotics and Adherence in Schizophrenic Patients: A Cross-sectional Study in Saudi Arabia

  2023cites this paper
• Metacognition in Schizophrenia Spectrum Disorders—Current Methods and Approaches

  2023cites this paper
• Neural bases of reward anticipation in healthy individuals with low, mid, and high levels of schizotypy

  2023cites this paper
• Using virtual reality to assess gesture performance deficits in schizophrenia patients

  2023cites this paper
• Negative Symptom Inventory-Self-Report (NSI-SR): Initial development and validation.

  2023cites this paper
• Cognitive Dysfunctions Measured with the MCCB in Deficit and Non-Deficit Schizophrenia

  2023influential citation
• Executive Functions and Psychopathology Dimensions in Deficit and Non-Deficit Schizophrenia

  2023influential citation
• Validity and reliability of a Chinese version of the self‐evaluation of negative symptoms

  2023cites this paper
• Efficacy and auditory biomarker analysis of fronto-temporal transcranial direct current stimulation (tDCS) in targeting cognitive impairment associated with recent-onset schizophrenia: study protocol for a multicenter randomized double-blind sham-controlled trial

  2023cites this paper
• Preliminary evidence that fatigue contributes to anhedonia in stable individuals diagnosed with schizophrenia

  2023cites this paper
• Correlation of Health-Related Quality of Life with Negative Symptoms Assessed with the Self-Evaluation of Negative Symptoms Scale (SNS) and Cognitive Deficits in Schizophrenia: A Cross-Sectional Study in Routine Psychiatric Care

  2023cites this paper
• Experiencing hallucinations in daily life: The role of metacognition.

  2023cites this paper
• Brain Stimulation and Group Therapy to Improve Gesture and Social Skills in Schizophrenia—The Study Protocol of a Randomized, Sham-Controlled, Three-Arm, Double-Blind Trial

  2022cites this paper
• Primary and Secondary Negative Symptoms in Schizophrenia

  2022cites this paper
• Psychometric properties of the BIRT Motivation Questionnaire (BMQ), a self-measure of avolition in individuals with schizophrenia.

  2022cites this paper
• The Deficit Schizophrenia Subtype Is Associated with Low Adherence to the Mediterranean Diet: Findings from a Case–Control Study

  2022cites this paper
• European Validation of the Self-Evaluation of Negative Symptoms (SNS): A Large Multinational and Multicenter Study

  2022cites this paper
• Psychopathology and Integrity of the Superior Longitudinal Fasciculus in Deficit and Nondeficit Schizophrenia

  2022cites this paper
• The Impact of Poor Nonverbal Social Perception on Functional Capacity in Schizophrenia

  2022cites this paper
• The role of attachment and dissociation in the relationship between childhood interpersonal trauma and negative symptoms in psychosis

  2022influential citation
• Perception of belonging and social anticipatory pleasure: Mediating variables of negative symptoms in the general population

  2022influential citation
• Validation of a European Spanish adaptation of the Apathy Evaluation Scale-self-rated version (AES-S) in patients with schizophrenia.

  2022cites this paper
• Validation of a European Spanish-version of the Self-Evaluation of Negative Symptoms (SNS) in patients with schizophrenia.

  2022cites this paper
• The Relationship Between the Recognition of Basic Emotions and Negative Symptoms in Individuals With Schizophrenia Spectrum Disorders – An Exploratory Study

  2022cites this paper
• Theories and models of negative symptoms in schizophrenia and clinical implications

  2022cites this paper
• Validation of the Turkish version of the self-evaluation of negative symptoms scale (SNS)

  2022influential citation
• Updated perspectives on the clinical significance of negative symptoms in patients with schizophrenia

  2022influential citation
• Mindfulness, cognitive fusion, and self-compassion in patients with schizophrenia spectrum disorders—A cross-sectional study

  2022cites this paper
• Virtual Reality Therapy for the Negative Symptoms of Schizophrenia (V-NeST): A pilot randomised feasibility trial.

  2022cites this paper
• Bridge centrality network structure of negative symptoms in people with schizophrenia

  2022cites this paper
• E cacy and auditory biomarker analysis of fronto- temporal transcranial direct current stimulation (tDCS) in targeting cognitive impairment associated with recent-onset schizophrenia: study protocol for a multicentric randomized double-blind sham- controlled trial

  2022cites this paper
• Impaired Effort Allocation in Patients with Recent-Onset Schizophrenia and Its Relevance to Negative Symptoms Assessments and Persistent Negative Symptoms

  2022influential citation
• The CHALLENGE trial: the effects of a virtual reality-assisted exposure therapy for persistent auditory hallucinations versus supportive counselling in people with psychosis: study protocol for a randomised clinical trial

  2022cites this paper
• Negative symptoms in alcohol use disorder: A pilot study applying the two-factor model of negative symptoms to patients with alcohol use disorder

  2022cites this paper
• Effectiveness of Psycho-Motivational Training on Improving Social Skills and Emotional Regulation in Patients with Schizophrenia

  2022influential citation
• Metacognitive training for negative symptoms: Support for the cognitive model.

  2022cites this paper
• EPA guidance on assessment of negative symptoms in schizophrenia

  2021influential citation
• Intermittent theta burst stimulation for negative symptoms of schizophrenia—A double-blind, sham-controlled pilot study

  2021cites this paper
• Awareness of illness moderates self-assessment of psychotic symptoms

  2021cites this paper
• Examining transcranial random noise stimulation as an add-on treatment for persistent symptoms in schizophrenia (STIM’Zo): a study protocol for a multicentre, double-blind, randomized sham-controlled clinical trial

  2021cites this paper
• Validity and reliability of a Persian version of the self- evaluation of negative symptoms (SNS)

  2021influential citation
• Altered neuroaxonal integrity in schizophrenia and major depressive disorder assessed with neurofilament light chain in serum.

  2021cites this paper
• White Matter Integrity of the Corpus Callosum and Psychopathological Dimensions in Deficit and Non-Deficit Schizophrenia Patients

  2021cites this paper
• Latent structure of self-report negative symptoms in patients with schizophrenia: A preliminary study.

  2021cites this paper
• [Validation of a French version of the 16-item Prodromal Questionnaire (fPQ16) in adolescents and young adults seeking help].

  2021cites this paper
• Improving cognition in severe mental illness by combining cognitive remediation and transcranial direct current stimulation: study protocol for a pragmatic randomized controlled pilot trial (HEADDSET)

  2021cites this paper
• Association of Negative Symptoms of Schizophrenia Assessed by the BNSS and SNS Scales With Neuropsychological Performance: A Gender Effect

  2021influential citation
• Clinical validation of the Symptom Self-rating Scale for Schizophrenia (4S) among inpatients

  2021cites this paper
• Self-evaluation of negative symptoms in adolescent and young adult first psychiatric episodes.

  2020cites this paper
• Negative Symptoms and Their Assessment in Schizophrenia and Related Disorders

  2020cites this paper
• Negative symptoms at the prodromal stage of schizophrenia at a young age (current problems of diagnostics and treatment)

  2020cites this paper
• Development and validation of a new adolescent self-report scale to measure loss of interest and pleasure: The Anhedonia Scale for Adolescents.

  2020cites this paper
• Validation of the lithuanian version of the self-evaluation of negative symptoms scale (SNS)

  2020cites this paper